Analytical method development, validation and stability study of ORC-13661
Active Awarded Last action
- Contract number
- 75N95022F00002
- Awardee
-
Mriglobal UEI HKQHNFKNKL15
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $482,032
Award facts
- Opportunity
-
- 75N95022R00090 Solicitation number
- Contract value 78% obligated
-
- $482,032.00 Current, with exercised options
- $615,530.00 Potential, with all options
- Completion date 86% complete
- Current and potential, with all options
- Funding agency
- National Center for Advancing Translational Sciences National Institutes of Health, Department of Health and Human Services
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Kansas City, MO 64110, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $20,648 | |
| Exercise an Option | $288,603 | |
| Original award | $172,781 |
About this award
The National Institutes of Health National Center for Advancing Translational Sciences awarded a $594,882 delivery order contract to Midwest Research Institute, doing business as Mriglobal, for Analytical Method Development, Validation and Stability Study of ORC-13661. This delivery order was issued against the prime contractor's master indefinite-delivery indefinite-quantity contract for Contract Research Organization Support for Drug Substance Development and Manufacture. Performance will take place in Kansas City, Missouri over a five-year period ending in September 2027. The contract utilizes a cost plus fixed fee pricing structure.
Quick answers
Who was awarded contract 75N95022F00002?
75N95022F00002 was awarded to Mriglobal by National Institute on Drug Abuse (National Institutes of Health) on September 29, 2022.
How much is contract 75N95022F00002 worth?
The government has obligated $482,032 on 75N95022F00002. Its potential value, with all options, is $615,530.
Which agency awarded contract 75N95022F00002?
National Institute on Drug Abuse (National Institutes of Health) awarded 75N95022F00002, with funding from National Center for Advancing Translational Sciences (National Institutes of Health).
Is contract 75N95022F00002 an order under another contract?
Yes. 75N95022F00002 is a delivery order under HHSN271201700006I, an indefinite delivery contract, on CRO Support for NCATS Drug Substance Development and Manufacture.
Was contract 75N95022F00002 competed?
The extent of competition for 75N95022F00002 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award